Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

BACKGROUND: Hyperlipidemia secondary to protease inhibitors (PI) may abate by switching to anti-HIV medications without lipid effects. METHOD: An open-label, randomized pilot study compared changes in fasting lipids and HIV-1 RNA in 104 HIV-infected adults with PI-associated hyperlipidemia (fasting...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	BMC Infect Dis
Hauptverfasser:	Keiser, Philip H, Sension, Michael G, DeJesus, Edwin, Rodriguez, Allan, Olliffe, Jeffrey F, Williams, Vanessa C, Wakeford, John H, Snidow, Jerry W, Shachoy-Clark, Anne D, Fleming, Julie W, Pakes, Gary E, Hernandez, Jaime E
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2005
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC548524/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15647105/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2334-5-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!